B. Lucchesi

发表

Profibrillatory Actions of Pinacidil in a Conscious Canine Model of Sudden Coronary Death

L. Chi, A. Uprichard, B. Lucchesi, 1990, Journal of cardiovascular pharmacology.

The Preparation and Characterization of Novel Peptide Antagonists to Thrombin and Factor VIIa and Activation of Protease-Activated Receptor 1

A. Schmaier, N. Brown, B. Lucchesi, 2004, Journal of Pharmacology and Experimental Therapeutics.

Recombinant single-chain urokinase-type plasminogen activator (rscu-PA) induces thrombolysis and systemic fibrinolysis in a canine model of coronary artery thrombosis.

P. J. Simpson, B. Lucchesi, W. Soehngen, 1988, Thrombosis research.

Electrophysiologic Actions of Lidocaine in a Canine Model of Chronic Myocardial Ischemic Damage—Arrhythmogenic Actions of Lidocaine

J. K. Gibson, B. Lucchesi, E. Patterson, 1982, Journal of cardiovascular pharmacology.

Antithrombotic effect of GYKI-14766 in a canine model of arterial and venous rethrombosis: a comparison with heparin.

B. Lucchesi, Y. Sudo, 1996, Journal of cardiovascular pharmacology.

Expert Answers to Three Key Questions How important is oxidative stress in ischemia , reperfusion , and heart failure ?

B. Lucchesi, G. Ambrosio, I. Tritto, 2004 .

Free radicals and tissue injury

B. Lucchesi, 1998 .

Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog

M. Schork, S. Kunkel, B. Lucchesi, 1983, Circulation.

High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury.

B. Lucchesi, P. Hoff, J. Fantone, 1993, Journal of the American College of Cardiology.

Experimental Models for the Assessment of Antiarrhythmic and Proarrhythmic Drug Action: Traditional and Newer Models

B. Lucchesi, G. Friedrichs, S. Black, 1995 .

UK-68,798, a class III antiarrhythmic drug with antifibrillatory properties

B. Lucchesi, S. Black, 1992 .

The Antithrombotic Effect of Melagatran in Combination With Clopidogrel and/or Aspirin (carotid artery primary thrombosis study)

B. Lucchesi, Jinbao Huang, E. Driscoll, 2005, Journal of cardiovascular pharmacology.

Risk of Ventricular Proarrhythmia with Selective Opening of the Myocardial Sarcolemmal versus Mitochondrial ATP-Gated Potassium Channel

B. Lucchesi, T. Barrett, P. Fischbach, 2004, Journal of Pharmacology and Experimental Therapeutics.

SNC-80-induced Preconditioning: Selective Activation of the Mitochondrial Adenosine Triphosphate-gated Potassium Channel

B. Lucchesi, T. Barrett, P. Fischbach, 2003, Journal of cardiovascular pharmacology.

Preconditioning reduces myocardial complement gene expression in vivo.

P. Mcgeer, E. Mcgeer, B. Lucchesi, 2000, American journal of physiology. Heart and circulatory physiology.

Preconditioning reduces tissue complement gene expression in the rabbit isolated heart.

P. Mcgeer, B. Lucchesi, K. Yasojima, 1999, The American journal of physiology.

Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion.

E. Bates, B. Lucchesi, S. Rebello, 1999, European journal of pharmacology.

Preconditioning reduces tissue complement gene expression in the rabbit isolated heart.

P. Mcgeer, B. Lucchesi, K. Yasojima, 1999, American journal of physiology. Heart and circulatory physiology.

Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death.

W. Kou, L. DiCarlo, B. Lucchesi, 1987, Journal of the American College of Cardiology.

Disodium Disuccinate Astaxanthin Prevents Carotid Artery Rethrombosis and ex vivo Platelet Activation

B. Lucchesi, E. Driscoll, D. Lauver, 2008, Pharmacology.

Heat Shock Proteins and the Ischemic Heart An Endogenous Protective Mechanism

B. Lucchesi, S. Black, 1993, Circulation.

Myocardial Reperfusion Injury—Role of Free Radicals and Mediators of Inflammation

B. Lucchesi, 2001 .

polyethylene glycol結合型superoxide dismutaseの心筋梗塞巣縮小効果

B. Lucchesi, 裕男田村, 頴斎藤, 1989 .

Superoxide Dismutase Conjugated to Polyethylene Glycol Provides Sustained Protection Against Myocardial Ischemia/ Reperfusion Injury in Canine Heart

K. Gallagher, B. Freeman, L. Chi, 1988, Circulation research.

The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase.

B. Pitt, S. Werns, B. Lucchesi, 1985, Circulation research.

Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart.

B. Pitt, M. Schork, S. Werns, 1986, Circulation.

Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals.

S. Kunkel, B. Lucchesi, J. Fantone, 1986, Circulation.

The Effect of Ibuprofen on Accumulation of Indium‐111‐labeled Platelets and Leukocytes in Experimental Myocardial Infarction

M. Schork, B. Lucchesi, D. Swanson, 1982, Circulation.

Effect of BW755C in an occlusion-reperfusion model of ischemic myocardial injury.

B. Lucchesi, S. Jolly, S R Jolly, 1983, American heart journal.

Beneficial effects of nafazatrom on ischemic reperfused myocardium.

B. Pitt, B. Lucchesi, S. Jolly, 1984, European journal of pharmacology.

Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion.

S. Kunkel, B. Lucchesi, S. Jolly, 1986, American heart journal.

Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation.

P. J. Simpson, K. Gallagher, M. Schork, 1987, American heart journal.

Iloprost Inhibits Neutrophil Function In Vitro and In Vivo and Limits Experimental Infarct Size in Canine Heart

P. J. Simpson, K. Gallagher, B. Lucchesi, 1987, Circulation research.

Sustained Limitation by Superoxide Dismutase of Canine Myocardial Injury Due to Regional Ischemia Followed by Reperfusion

P. J. Simpson, B. Pitt, S. Werns, 1988, Journal of cardiovascular pharmacology.

Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.

P. J. Simpson, J. Griffin, B. Lucchesi, 1988, The Journal of clinical investigation.

Occlusion-reperfusion model of ischemic injury

B. Pitt, B. Lucchesi, S. Jolly, 2002 .

Combined adenosine and lidocaine administration limits myocardial reperfusion injury.

B. Lucchesi, P. Hoff, J. Homeister, 1990, Circulation.

Anti-Inflammatory Properties of Monoclonal Anti-Mo1 (CD11b/CD18) Antibodies In Vitro and In Vivo

P. J. Simpson, B. Lucchesi, R. Todd, 1990 .

Streptokinase improves reperfusion blood flow after coronary artery occlusion.

P. J. Simpson, B. Lucchesi, J. Mickelson, 1989, International journal of cardiology.

Free radicals and myocardial ischemia and reperfusion injury.

P. J. Simpson, B. Lucchesi, Paul J. Simpson, 1987, The Journal of laboratory and clinical medicine.

Official Jiournal of the cAmerican Heart cyAssociation , Inc . FEATURES Free radicals and myocardial injury : pharmacologic implications

S. Werns, B. Lucchesi, M. Shea, 2005 .

Myocardial ischemia and reperfusion: The role of oxygen radicals in tissue injury

S. Werns, B. Lucchesi, 2004, Cardiovascular Drugs and Therapy.

Xanthine Oxidase Inhibition Does Not Limit Canine Infarct Size

M. Schork, S. Werns, B. Lucchesi, 1991, Circulation.

The Role of the Polymorphonuclear Leukocyte in Mediating Myocardial Reperfusion Injury

S. Werns, B. Lucchesi, 1988 .

Free radicals and myocardial injury: pharmacologic implications.

S. Werns, B. Lucchesi, M. Shea, 1986, Circulation.

Free radicals in ischemic myocardial injury.

S. Werns, B. Lucchesi, M. Shea, 1985, Journal of Free Radicals in Biology & Medicine.

Canine Myocardial Reperfusion Injury: Protection by a Free Radical Scavenger, N‐2‐Mcrcaptopropionyl Glycine

P. J. Simpson, K. Gallagher, M. Schork, 1986, Journal of cardiovascular pharmacology.

Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.

P. J. Simpson, K. Gallagher, B. Lucchesi, 1988, The Journal of pharmacology and experimental therapeutics.

Time-dependent changes in canine cardiac mitochondrial function and ultrastructure resulting from coronary occlusion and reperfusion

B. Lucchesi, L. Bush, M. Shlafer, 1980, Basic Research in Cardiology.

An isolated, blood-perfused, feline heart preparation for evaluating pharmacological interventions during myocardial ischemia.

B. Lucchesi, W. Vogel, 1980, Journal of pharmacological methods.

Inability of Methylprednisolone Sodium Succinate to Decrease Infarct Size or Preserve Enzyme Activity Measured 24 Hours after Coronary Occlusion in the Dog

B. Lucchesi, G. Abrams, W. Vogel, 1977, Circulation.

The role of the neutrophil and free radicals in ischemic myocardial injury.

S. Werns, B. Lucchesi, J. Fantone, 1989, Journal of molecular and cellular cardiology.

Effects of dimethyl quaternary propranolol (UM-272) on oxygen consumption and ischemic ST segment changes in the canine heart.

B. Lucchesi, W. Burmeister, F. Kniffen, 1975, The Journal of pharmacology and experimental therapeutics.

Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).

B. Lucchesi, G. Abrams, W. Burmeister, 1976, The Journal of pharmacology and experimental therapeutics.

Effects of Dimethyl Propranolol (UM-272; SC-27761) on Myocardial Ischemic Injury in the Canine Heart after Temporary Coronary Artery Occlusion

B. Lucchesi, D. Ku, 1978, Circulation.

Apoptosis in myocardial infarction

J. Schaper, B. Lucchesi, M. Rodriguez, 2002, Annals of medicine.

Complement activation and inhibition in myocardial ischemia and reperfusion injury.

B. Lucchesi, J. Homeister, 1994, Annual review of pharmacology and toxicology.

Leukocytes and ischemia-induced myocardial injury.

B. Lucchesi, K. Mullane, 1986, Annual review of pharmacology and toxicology.

Effects of Diltiazem on Extent of Ultimate Myocardial Injury Resulting from Temporary Coronary Artery Occlusion in Dogs

J. L. Ash, B. Lucchesi, L. Bush, 1982, Journal of cardiovascular pharmacology.

Myocardial Ischemia: The Potential Therapeutic Role of Prostacyclin and Its Analogues

P. J. Simpson, B. Lucchesi, 1987 .

LEUKOCYTES, OXYGEN RADICALS, AND MYOCARDIAL TO ISCHEMIA AND REPERFUSION* INJURY DUE

B. Lucchesi, W. Steven, 1988 .

Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol.

B. Lucchesi, J. Lynch, E. Patterson, 1984, The Journal of pharmacology and experimental therapeutics.

Reduction by Superoxide Dismutase but not Catalase

B. Pitt, S. Werns, B. Lucchesi, 2005 .

Chimeric 7E3 Prevents Carotid Artery Thrombosis in Cynomolgus Monkeys

H. Weisman, M. Nedelman, B. Lucchesi, 1994, Stroke.

Hirudin and S18886 Maintain Luminal Patency After Thrombolysis With Alfimeprase

B. Lucchesi, F. Markland, Jullia Y. Lee, 2013, Journal of cardiovascular pharmacology.

Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury.

B. Lucchesi, A. Cardin, T. Hong, 2006, Thrombosis research.

Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury.

B. Lucchesi, A. Cardin, J. Hennan, 2002, The Journal of pharmacology and experimental therapeutics.

Protective effects of β-adrenergic blockade in isolated ischemic hearts☆

B. Lucchesi, L. Bush, M. Shlafer, 1980 .

Prevention of carotid artery thrombosis by oral platelet GPIIb/IIIa antagonist in dogs.

S. Mousa, B. Lucchesi, D. Mu, 1997, Stroke.

Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysis.

P. J. Simpson, B. Lucchesi, J. Mickelson, 1987, American heart journal.

Heparin Neutralization by Platelet-Rich Thrombi

R. Schwartz, D. Eitzman, L. Chi, 2005 .

Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4.

R. Schwartz, D. Eitzman, L. Chi, 1994, Circulation.

Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion.

B. Lucchesi, E. Booth, E. A. Booth, 2007, American journal of physiology. Heart and circulatory physiology.

The Pathway-Selective Estrogen Receptor Ligand WAY-169916 Reduces Infarct Size After Myocardial Ischemia and Reperfusion by an Estrogen Receptor Dependent Mechanism

B. Lucchesi, M. Marchesi, E. Booth, 2007, Journal of cardiovascular pharmacology.

Mitochondrial function after global cardiac ischemia and reperfusion: Influences of organelle isolation protocols

S. Warren, B. Lucchesi, M. Kirsh, 1981, Basic Research in Cardiology.

HBI-3000 Prevents Secondary Sudden Cardiac Death

B. Lucchesi, Jullia Y. Lee, 2013, Journal of cardiovascular pharmacology and therapeutics.

Antiarrhythmic versus antifibrillatory actions: inference from experimental studies.

L. Chi, A. Uprichard, B. Lucchesi, 1993, The American journal of cardiology.

Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration.

B. Lucchesi, G. Abrams, E. Patterson, 1983, Circulation.

Microvascular permeabilization and cardiomyocyte injury provoked by myocardial contrast echocardiography in a canine model.

Douglas L. Miller, B. Lucchesi, Chunyan Dou, 2006, Journal of the American College of Cardiology.

Cardiac Arrhythmia and Injury Induced in Rats by Burst and Pulsed Mode Ultrasound With a Gas Body Contrast Agent

Douglas L. Miller, B. Lucchesi, Chunyan Dou, 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Tedisamil in a chronic canine model of atrial flutter.

B. Lucchesi, G. Friedrichs, P. Fischbach, 1999, Journal of cardiovascular pharmacology.

Effects of tedisamil (KC‐8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart

James L. Park, L. Chi, B. Lucchesi, 1996, British journal of pharmacology.

Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol.

B. Lucchesi, D. Wilber, J. Lynch, 1984, Journal of cardiovascular pharmacology.

Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death.

B. Lucchesi, J. Lynch, D. Montgomery, 1985, American heart journal.

Electrophysiology and Antiarrhythmic Actions of E‐4031 in the Experimental Animal Model of Sudden Coronary Death

L. Chi, B. Lucchesi, D. Mu, 1991, Journal of cardiovascular pharmacology.

Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.

B. Lucchesi, 1984, The American journal of cardiology.

Prostaglandins and prostaglandin inhibitors in ischemic heart disease.

B. Pitt, B. Lucchesi, J. Romson, 1983, Annals of internal medicine.

Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart.

B. Lucchesi, G. Friedrichs, K. Kilgore, 1994, Circulation research.

Nitroglycerin inhibits experimental thrombosis and reocclusion after thrombolysis.

S. Werns, B. Lucchesi, J. Davis, 1994, American heart journal.

Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries

L. Crofford, B. Lucchesi, T. Barrett, 2001, Circulation.

Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion.

P. Mcgeer, B. Lucchesi, K. Yasojima, 1998, Circulation research.

The pharmacology of beta-adrenergic blocking agents.

B. Lucchesi, L. S. Whitsitt, 1969, Progress in cardiovascular diseases.

Oxygen radicals: Systemic events and disease processes

B. Lucchesi, 1990 .

Antifibrillatory effects of ibutilide in the rabbit isolated heart: mediation via ATP-dependent potassium channels.

J. Oh, L. Chi, B. Lucchesi, 1993, Journal of Pharmacology and Experimental Therapeutics.

Modulation of leukocyte-mediated myocardial reperfusion injury.

B. Lucchesi, B R Lucchesi, 1990, Annual review of physiology.

Actions of Pinacidil at a Reduced Potassium Concentration: A Direct Cardiac Effect Possibly Involving the ATP‐Dependent Potassium Channel

L. Chi, B. Lucchesi, Philip I. Kuo, 1993, Journal of cardiovascular pharmacology.

Therapeutic advances in the management of cardiac arrhythmias: III - Verapamil

B. Lucchesi, E. Patterson, 1982 .

Protective effects of AICAriboside in the globally ischemic isolated cat heart.

B. Lucchesi, S. Jolly, S. E. Mitsos, 1985, Pharmacology.

Reduction in digitalis-associated postinfarction mortality with nadolol in conscious dogs.

B. Lucchesi, P. Hoff, J. Lynch, 1988, American heart journal.

Facilitation of lethal ventricular arrhythmias by therapeutic digoxin in conscious post infarction dogs.

B. Lucchesi, J. Lynch, D. Montgomery, 1986, American heart journal.

Ischemic-induced alterations in cardiac sensitivity to digitalis.

B. Lucchesi, D. Ku, 1979, European journal of pharmacology.

Deficiency of leukocyte surface glycoproteins Mo1, LFA-1, and Leu M5 in a dog with recurrent bacterial infections: an animal model.

U. Giger, B. Lucchesi, L. Boxer, 1987, Blood.

The Renin – Angiotensin – Aldosterone System and Other Vasoactive Substances 206

P. A. Friedman, W. Berndt, G. Gross, 2003 .

TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog.

B. Lucchesi, S. Rebello, E. Driscoll, 1997, Stroke.

Electrophysiologic and Antiarrhythmic Effects of Phentolamine in Experimental Coronary Artery Occlusion and Reperfusion in the Dog

B. Lucchesi, J. Stewart, W. Burmeister, 1980, Journal of cardiovascular pharmacology.

Preclinical Evaluation of S18886 in an Experimental Model of Coronary Arterial Thrombosis

B. Lucchesi, Jinbao Huang, E. Driscoll, 2006, Journal of cardiovascular pharmacology.

2001 Torald Sollmann Award lecture. Looking toward the future, using lessons from the past.

B. Lucchesi, 2001, The Journal of pharmacology and experimental therapeutics.

Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model.

P. J. Simpson, E. Laywell, B. Lucchesi, 1990, Circulation.

Role of neutrophils in ischemic heart disease: pathophysiologic role in myocardial ischemia and coronary artery reperfusion.

B. Lucchesi, 1987, Cardiovascular clinics.

Leukocytes, oxygen radicals, and myocardial injury due to ischemia and reperfusion.

S. Werns, B. Lucchesi, 1988, Free radical biology & medicine.

Protective effects of the SOD-mimetic SC-52608 against ischemia/reperfusion damage in the rabbit isolated heart.

U. Ryan, B. Lucchesi, D. Riley, 1994, Journal of molecular and cellular cardiology.

Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection.

B. Lucchesi, E. J. Tanhehco, H. Lee, 2000, Immunopharmacology.

Antifibrillatory Actions of d, l‐Nadolol in a Conscious Canine Model of Sudden Coronary Death

B. Lucchesi, E. Patterson, 1983, Journal of cardiovascular pharmacology.

Effects of the Positive Inotropic Agents Milrinone and Pimobendan on the Development of Lethal Ischemic Arrhythmias in Conscious Dogs with Recent Myocardial Infarction

A. Uprichard, B. Lucchesi, J. Lynch, 1989, Journal of cardiovascular pharmacology.

Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents.

B. Lucchesi, J. Romson, D. W. Haack, 1980, Thrombosis research.

Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart.

P. J. Simpson, B. Lucchesi, J. Mickelson, 1988, Journal of molecular and cellular cardiology.

Platelet‐Activating Factor and the Release of a Platelet‐Derived Coronary Artery Vasodilator Substance in the Canine

S. Kunkel, B. Lucchesi, W. Schumacher, 1986, Circulation research.

Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis.

B. Lucchesi, S. Rebello, H. S. Blank, 2000, Thrombosis research.

Myocardial glutathione depletion impairs recovery of isolated blood-perfused hearts after global ischaemia.

S. Werns, B. Lucchesi, J. Fantone, 1992, Journal of molecular and cellular cardiology.

Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion.

B. Lucchesi, R. Marks, K. Kilgore, 1998, Journal of molecular and cellular cardiology.

Effects of complement activation in the isolated heart. Role of the terminal complement components.

B. Lucchesi, P. Satoh, J. Homeister, 1992, Circulation research.

Pharmacological Modification of Arrhythmias After Experimentally Induced Acute Myocardial Infarction: Drugs Acting on the Nervous System

B. Lucchesi, F. Kniffen, FRANK J. KNIFFEN, 1975, Circulation.

Are ECG premature complexes induced by ultrasonic cavitation electrophysiological responses to irreversible cardiomyocyte injury?

Douglas L. Miller, B. Lucchesi, Chunyan Dou, 2011, Ultrasound in medicine & biology.

Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model.

B. Lucchesi, D. Wilber, J. Lynch, 1985, American heart journal.

Comparative Effects of Prenalterol and Dobutamine in a Canine Model of Acute Ischemic Heart Failure

B. Pitt, B. Lucchesi, P. Kirlin, 1981, Journal of cardiovascular pharmacology.

Protective effects of diltiazem during myocardial ischemia in isolated cat hearts.

B. Lucchesi, S. Jolly, L. Bush, 1981, The Journal of pharmacology and experimental therapeutics.

O2 free radical-mediated myocardial and vascular dysfunction.

B. Lucchesi, J. Mickelson, P. S. Rao, 1986, The American journal of physiology.

Increase in experimental infarct size with digoxin in a canine model of myocardial ischemia-reperfusion injury.

P. J. Simpson, K. Gallagher, B. Lucchesi, 1988, American heart journal.

Cardioprotective effects of amlodipine in the ischemic-reperfused heart.

B. Lucchesi, P. Hoff, Y. Tamura, 1989, The American journal of cardiology.

ISCHEMIA-INDUCED MYOCARDIAL INJURY

B. Lucchesi, K. Mullane, 1986 .

Propranolol (Inderal) in experimentally-induced cardiac arrhythmias.

B. Lucchesi, L. S. Whitsitt, N. L. Brown, 1966, Canadian journal of physiology and pharmacology.

The complement system in myocardial ischaemia/reperfusion injury.

B. Lucchesi, J. Homeister, G. Friedrichs, 1994, Cardiovascular research.

Disodium Disuccinate Astaxanthin (Cardax) Attenuates Complement Activation and Reduces Myocardial Injury following Ischemia/Reperfusion

B. Lucchesi, S. F. Lockwood, D. Lauver, 2005, Journal of Pharmacology and Experimental Therapeutics.

Orally effective CVS-1123 prevents coronary artery thrombosis in the conscious dog.

B. Lucchesi, S. Rebello, G. Vlasuk, 1996, Circulation.

Glucagon: Its Enhancement of Atrioventricular Nodal Pacemaker Activity and Failure to Increase Ventricular Automaticity in Dogs

J. L. Brown, B. Lucchesi, R. Winfield, 1969, Circulation research.

Augmentation of Streptokinase‐Induced Thrombolysis by Heparin and Prostacyclin

B. Lucchesi, W. Schumacher, E. Lee, 1985, Journal of cardiovascular pharmacology.

Cardioprotective Effects of Ibuprofen in Experimental Regional and Global Myocardial Ischemia

B. Lucchesi, S. Jolly, L. Bush, 1982, Journal of cardiovascular pharmacology.

Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist.

W. DeGrado, S. Mousa, B. Lucchesi, 1996, Circulation.

Prevention of Rethrombosis After Coronary Thrombolysis in a Chronic Canine Model. I. Adjunctive Therapy with Monoclonal Antibody 7E3 F(ab')2 Fragment

E. Bates, M. Nedelman, B. Lucchesi, 1994, Journal of cardiovascular pharmacology.

Coronary Artery Vasodilation in the Canine: Physiological and Pharmacological Roles of β‐Adrenergic Receptors

B. Lucchesi, C. Jackson, T. Pope, 1987, Journal of cardiovascular pharmacology.

α‐Adrenergic Influences in Canine Ischemic Sudden Death: Effects of α1-Adrenoceptor Blockade with Prazosin

B. Lucchesi, D. Wilber, J. Lynch, 1987 .

Alpha-adrenergic influences in canine ischemic sudden death: effects of alpha 1-adrenoceptor blockade with prazosin.

B. Lucchesi, D. Wilber, J. Lynch, 1987, Journal of cardiovascular pharmacology.

Effects of diltiazem upon experimental ventricular dysrhythmias.

B. Lucchesi, E. Patterson, B. T. Eller, 1983, The Journal of pharmacology and experimental therapeutics.

Sildenafil Citrate for Prophylaxis of Nephropathy in an Animal Model of Contrast-Induced Acute Kidney Injury

H. Gurm, I. Bergin, B. Lucchesi, 2014, PloS one.

Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase.

B. Lucchesi, Jinbao Huang, T. Hong, 2006, American journal of physiology. Heart and circulatory physiology.

The Comparative Antiarrhythmic Actions of Lidocaine and its Quarternary Derivative, Methyl Lidocaine

B. Lucchesi, F. Kniffen, T. E. Lomas, 1974, Circulation.

Sustained inhibition of the vessel wall‐platelet interaction after deep coronary artery injury by temporary inhibition of the platelet glycoprotein llb/llla receptor

E. Bates, B. Lucchesi, G. Abrams, 1992 .

Antiplatelet monoclonal F(ab')2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart.

P. J. Simpson, B. Lucchesi, J. Mickelson, 1989, Journal of molecular and cellular cardiology.

Phorbol ester-induced ventricular fibrillation in the Langendorff-perfused rabbit heart: antagonism by staurosporine and glibenclamide.

L. Chi, B. Lucchesi, G. Friedrichs, 1993, Journal of Molecular and Cellular Cardiology.

Scintigraphic detection of regional disruption of adrenergic neurons in the heart.

B. Lucchesi, J. Sisson, J. Lynch, 1988, American heart journal.

Reduction oftheExtent ofIschemic Myocardial Injury byNeutrophil Depletion intheDog

B. Lucchesi, J. Romson, M. Anthonyschork, 1983 .

BMY21190, A Potent Inhibitor of cAMP Phosphodiesterase

M. Minami, M. Hirafuji, B. Lucchesi, 1994 .

Prevention of Occlusive Coronary Artery Thrombosis by Prostacyclin Infusion in the Dog

B. Lucchesi, G. Abrams, J. Romson, 1981, Circulation.

Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction

James L. Park, W. O’Neill, B. Lucchesi, 2001, Perfusion.

Pharmacokinetics and pharmacodynamics of SM-20302, a GPIIb/IIIa receptor antagonist, in anesthetized dogs.

B. Lucchesi, S. Rebello, K. Saito, 1998, Journal of cardiovascular pharmacology.

In vivo efficacy of SM-20302, a GP IIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood.

B. Lucchesi, S. Rebello, K. Saito, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.

J. Borlak, B. Lucchesi, J. Borlak, 1998, Journal of cardiovascular pharmacology.

Electrophysiologic and antiarrhythmic actions of nadolol: acute ischemia in the presence of previous myocardial infarction.

B. Lucchesi, E. Patterson, 1988, American heart journal.

Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.

B. Lucchesi, E. Patterson, K. Holland, 1983, American heart journal.

Tedisamil and dofetilide‐induced torsades de pointes, rate and potassium dependence

B. Lucchesi, T. Barrett, J. Hennan, 2001, British journal of pharmacology.

Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.

B. Lucchesi, E. Patterson, 1984, Pharmacology.

5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death.

L. Chi, B. Lucchesi, G. Friedrichs, 1996, European Journal of Pharmacology.

Protective Effects of Ranolazine on Ventricular Fibrillation Induced by Activation of the ATP-Dependent Potassium Channel in the Rabbit Heart

James L. Park, J. Mccormack, L. Chi, 1996, Journal of cardiovascular pharmacology and therapeutics.

Effects of Adenosine on Thrombosis and Thrombolysis in a Canine Experimental Preparation

S. Werns, B. Lucchesi, Jinbao Huang, 2001, Pharmacology.

Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury.

B. Lucchesi, G. Friedrichs, K. Kilgore, 1995, Cardiovascular research.

In Vivo Models of Thrombosis

B. Lucchesi, S. Rebello, L. Chi, 1999 .

Tedisamil Attenuates Ventricular Fibrillation in a Conscious Canine Model of Sudden Cardiac Death

L. Chi, B. Lucchesi, J. Borlak, 1996, Journal of cardiovascular pharmacology and therapeutics.

Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.

B. Lucchesi, J. Lynch, D. Montgomery, 1985, The Journal of pharmacology and experimental therapeutics.

Antifibrillatory actions of nadolol.

B. Lucchesi, E. Patterson, 1982, The Journal of pharmacology and experimental therapeutics.

Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics.

B. Lucchesi, K. Kilgore, M. B. Anderson, 1998, The Journal of pharmacology and experimental therapeutics.

Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis.

B. Lucchesi, F. Markland, G. Friedrichs, 1994, Circulation.

ANTIARRHYTHMIC EFFECTS OF BETA ADRENERGIC BLOCKING AGENTS *

B. Lucchesi, L. S. Whitsitt, J. L. Stickney, 1967, Annals of the New York Academy of Sciences.

Myocardial Reperfusion: Role of Adjunctive Agents to Improve Reperfusion and Prevent Reperfusion Injury

B. Pitt, B. Lucchesi, 1989 .

Combined adenosine and lidocaine administration limits myocardial reperfusion injury

K. Gallagher, B. Lucchesi, P. Hoff, 1989 .

Antifibrillatory effects of clofilium in the rabbit isolated heart

L. Chi, B. Lucchesi, G. Friedrichs, 1994, British journal of pharmacology.

Protection Against Programmed Electrical Stimulation-Induced Ventricular Tachycardia and Sudden Cardiac Death by NE-10064, a Class III Antiarrhythmic Drug

B. Lucchesi, S. Black, J. L. Butterfield, 1993, Journal of cardiovascular pharmacology.

Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models.

B. Lucchesi, E. Patterson, M. Shea, 1985, European journal of pharmacology.

Ventricular fibrillation in a conscious canine model--its prevention by UM-272.

B. Lucchesi, E. Patterson, B. T. Eller, 1983, European journal of pharmacology.

Chronic Ventricular Tachyarrhythmias in the Conscious Dog: Prevention by UM‐272 (Dimethylpropranolol)

B. Lucchesi, E. Patterson, 1981, Journal of cardiovascular pharmacology.

Electrophysiologic effects of UM-272 on myocardial ischemia in the canine heart.

J. K. Gibson, B. Lucchesi, J. Burmeister, 1978, The Journal of pharmacology and experimental therapeutics.

The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.

B. Lucchesi, R. Counsell, F. Kniffen, 1975, The Journal of pharmacology and experimental therapeutics.

Antiarrhythmic and Electrophysiologic Actions of CK‐357 and Sematilide in a Conscious Canine Model of Sudden Coronary Death

L. Chi, B. Lucchesi, E. Driscoll, 1990, Journal of cardiovascular pharmacology.

Role of Calcium on Excitation‐Contraction Coupling in Cardiac and Vascular Smooth Muscle

B. Lucchesi, 1989, Circulation.

Conversion of Atrial Fibrillation by the Experimental Antiarrhythmic Drug Tedisamil in Two Canine Models

B. Lucchesi, T. Barrett, Z. Syed, 2001, Journal of cardiovascular electrophysiology.

Effect of ranolazine on infarct size in a canine model of regional myocardial ischemia/reperfusion.

J. Mccormack, B. Lucchesi, M. Gralinski, 1994, Journal of cardiovascular pharmacology.

Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart.

J. Mccormack, B. Lucchesi, K. Kilgore, 1994, Cardiovascular research.

Streptokinase thrombolysis in experimental coronary artery thrombosis: pattern of reflow and effect of a stenosis.

A. Buda, B. Lucchesi, W. Schumacher, 1984, International journal of cardiology.

Electrophysiologic actions and antifibrillatory efficacy of subacute left stellectomy in a conscious, post-infarction canine model of ischemic ventricular fibrillation.

B. Lucchesi, D. Sanders, S. Nelson, 1989, International journal of cardiology.

Complement, neutrophils and oxygen radicals in myocardial-ischemia reperfusion injury

B. Lucchesi, 1992 .

Effects of Propranolol and Its Stereoisomers upon Coronary Vascular Resistance

B. Lucchesi, L. S. Whitsitt, Leighton S. Whitsitt, 1967, Circulation research.

Glycoprotein IIb/IIIa Receptor Antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-{[2-({4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl}amino)acetyl]amino}propanoic Acid Dihydrochloride (CRL42796), in Combination with Aspirin and/or Enoxaparin, Prevents Coronary Artery Rethrombosis after Success

A. J. White, Andrew J. White, B. Lucchesi, 2003, Journal of Pharmacology and Experimental Therapeutics.

butanoyl } amino ) acetyl ] amino } propanoic Acid Dihydrochloride ( CRL 42796 ) , in Combination with Aspirin and / or Enoxaparin , Prevents Coronary Artery Rethrombosis after Successful Thrombolytic Treatment by Recombinant Tissue Plasminogen Activator

Andrew J. White, B. Lucchesi, E. Driscoll, 2003 .

Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanisms of myocardial ischemic injury.

J. Schaper, B. Lucchesi, S. Kostin, 2005, Journal of molecular and cellular cardiology.

Adrenergic-dependent Effect of Adenosine-induced Ventricular Fibrillation in the Isolated Rabbit Heart

James L. Park, L. Chi, B. Lucchesi, 1997, Journal of cardiovascular pharmacology and therapeutics.

Prothrombotic effects of thrombolytic therapy in a rat (Rattus norvegicus) model of venous thrombolysis.

K. Guire, T. Wakefield, I. Bergin, 2013, Comparative medicine.

Prevention of Carotid Artery Thrombosis After Oral Administration of the Glycoprotein IIb/IIIa Antagonist CRL42796

B. Lucchesi, J. Hennan, E. Driscoll, 2003, Journal of cardiovascular pharmacology.

Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796

B. Lucchesi, J. Hennan, E. Driscoll, 2002, British journal of pharmacology.

CVS-1123, a direct thrombin inhibitor, prevents occlusive arterial and venous thrombosis in a canine model of vascular injury.

B. Lucchesi, S. Rebello, B. V. Miller, 1997, Journal of cardiovascular pharmacology.

Thromboxane Antagonism in Experimental Canine Carotid Artery Thrombosis

B. Lucchesi, W. Rote, D. Mu, 1993, Stroke.

Identification of Hydrogen Peroxide and Hydroxyl Radical as Mediators of LeukocyteInduced Myocardial Dysfunction

M. Hess, B. Lucchesi, G. Rowe, 1985 .

Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart.

C. Sirtori, B. Lucchesi, G. Rossoni, 2008, Atherosclerosis.

EFFECT OF INFARCT SIZE LIMITATION BY PROPRANOLOL ON VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION

J. K. Gibson, B. Lucchesi, J. Stewart, 1982, Annals of the New York Academy of Sciences.

Reduction of myocardial infarct size after ischemia and reperfusion by the glycosaminoglycan pentosan polysulfate.

James L. Park, B. Lucchesi, K. Kilgore, 1999, Journal of cardiovascular pharmacology.

The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivo

B. Lucchesi, J. Fantone, R. Webb, 1991, Agents and Actions.

Platelet depletion in experimental myocardial infarction

S. Kunkel, B. Lucchesi, S. Jolly, 1985, Basic Research in Cardiology.

Role of the Terminal Complement Components

B. Lucchesi, P. Satoh, J. Homeister, 2005 .

N-Acetylheparin Pretreatment Reduces Infarct Size in the Rabbit

James L. Park, B. Lucchesi, K. Kilgore, 1999, Pharmacology.

Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage.

B. Lucchesi, M. Gralinski, B. Wiater, 1996, Immunopharmacology.

Prevention of Rethrombosis After Coronary Thrombolysis in a Chronic Canine Model. II. Adjunctive Therapy with r‐Hirudin

E. Bates, M. Nedelman, B. Lucchesi, 1994, Journal of cardiovascular pharmacology.

Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.

B. Lucchesi, W. Schumacher, 1983, The Journal of pharmacology and experimental therapeutics.

Monoclonal Antibody That Alters Leukocyte Function

P. J. Simpson, K. Gallagher, B. Lucchesi, 2005 .

The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.

B. Pitt, B. Lucchesi, J. Romson, 1984, American heart journal.

Protection of ischemic myocardium by pharmacologic manipulation of leukocyte function

B. Lucchesi, S. Jolly, J. Romson, 1992 .

Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction.

J. K. Gibson, B. Lucchesi, E. Patterson, 1980, The American journal of cardiology.

Disopyramide-induced ventricular tachycardia.

B. Pitt, P. Stetson, B. Lucchesi, 1980, Archives of internal medicine.

Alinidine Reduces the Incidence of Ischemic Ventricular Fibrillation in a Conscious Canine Model, a Protective Effect Antagonized by Overdrive Atrial Pacing

L. Chi, A. Uprichard, B. Lucchesi, 1989, Journal of cardiovascular pharmacology.

Antithrombotic efficacy of a recombinant nematode anticoagulant peptide (rNAP5) in canine models of thrombosis after single subcutaneous administration.

B. Lucchesi, S. Rebello, G. Vlasuk, 1997, The Journal of pharmacology and experimental therapeutics.

Correlation between the in vivoEff icacy of GPIIb/IIIa Receptor Antagonists (m7E3, MK-383 and DMP-728) and ex vivo Platelet Inhibition

J. Faul, B. Lucchesi, S. Rebello, 1999, Pharmacology.

Antithrombotic Effects of DMP 728, a Platelet GPIIb/IIIa Receptor Antagonist, in a Canine Model of Arterial Thrombosis

S. Mousa, B. Lucchesi, T. Reilly, 1994, Journal of cardiovascular pharmacology.

Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery.

S. Werns, B. Lucchesi, L. Feigen, 1993, Cardiovascular research.

Formation, Reactivity, and Antiplatelet Activity of Mixed Disulfide Conjugates of Clopidogrel

B. Lucchesi, P. Hollenberg, Haoming Zhang, 2013, Molecular Pharmacology.

The positive inotropic effect of glucagon in the chronically failed right ventricle as demonstrated in the isolated cat heart.

B. Lucchesi, S. Winokur, N. Nobel-Allen, 1975, European journal of pharmacology.

Acute cocaine exposure up-regulates complement expression in rabbit heart.

P. Mcgeer, B. Lucchesi, K. Yasojima, 2000, The Journal of pharmacology and experimental therapeutics.

Complement activation, neutrophils, and oxygen radicals in reperfusion injury.

B. Lucchesi, 1993, Stroke.

Oral and intravenous bretylium disposition

J. Wagner, J. Anderson, B. Lucchesi, 1980, Clinical pharmacology and therapeutics.

Free radicals and ischemic tissue injury.

S. Werns, B. Lucchesi, 1990, Trends in pharmacological sciences.

Effects of Lodoxamide on Ischemic Reperfused Myocardium

B. Lucchesi, S. Jolly, G. Abrams, 1982, Journal of cardiovascular pharmacology.

The Nitroglycerin Polymer Gel Matrix System: A New Method for Administering Nitroglycerin Evaluated with Plasma Nitroglycerin Levels

B. Pitt, P. Stetson, B. Lucchesi, 1982, Journal of cardiovascular pharmacology.

Intravenous prenalterol in acute and chronic heart failure.

B. Pitt, B. Lucchesi, P. Kirlin, 2009, Acta medica Scandinavica. Supplementum.

Interaction of the formed elements of blood with the coronary vasculature in vivo.

B. Lucchesi, J. Homeister, J. Mickelson, 1987, Federation proceedings.

Effects of Pimobendan (UD‐CG 115 BS), a New Positive Inotropic Agent, on Ventricular Tachycardia and Ischemic Ventricular Fibrillation in a Conscious Canine Model of Recent Myocardial Infarction

B. Lucchesi, P. Hoff, J. Lynch, 1988, Journal of cardiovascular pharmacology.

Antidysrhythmic actions of meobentine sulfate.

J. M. Zimmerman, B. Pitt, B. Lucchesi, 1984, American heart journal.

Antifibrillatory actions of bepridil and butyl-MDI, two intracellular calcium antagonists.

B. Lucchesi, J. Lynch, R. Rahwan, 1985, European journal of pharmacology.

Protective effects of beta-adrenergic blockade in isolated ischemic hearts.

B. Lucchesi, L. Bush, M. Shlafer, 1980, European journal of pharmacology.

Identification of a Time Window for Therapy to Reduce Experimental Canine Myocardial Injury: Suppression of Neutrophil Activation During 72 Hours of Reperfusion

P. J. Simpson, K. Gallagher, B. Lucchesi, 1988, Circulation research.

Mechanisms of myocardial reperfusion injury.

B. Lucchesi, B R Lucchesi, J L Park, 1999, The Annals of thoracic surgery.

Free radical scavengers in myocardial ischemia.

P. J. Simpson, B. Lucchesi, J. Mickelson, 1987, Federation proceedings.

Canine Myocardial Reperfusion Injury: Its Reduction by the Combined Administration of Superoxide Dismutase and Catalase

B. Lucchesi, S. Jolly, G. Abrams, 1984, Circulation research.

Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function.

P. J. Simpson, K. Gallagher, B. Lucchesi, 1990, Circulation.

Estrogen-Mediated Protection in Myocardial Ischemia-Reperfusion Injury

B. Lucchesi, E. Booth, E. A. Booth, 2008, Cardiovascular Toxicology.

Therapeutic potential of complement inhibitors in myocardial ischaemia

B. Lucchesi, E. J. Tanhehco, 2000, Expert opinion on investigational drugs.

Thrombogenesis with continuous blood flow in the inferior vena cava

T. Wakefield, B. Lucchesi, J. Diaz, 2010, Thrombosis and Haemostasis.

Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.

Michael L. Gonzales, B. Lucchesi, M. L. Gonzales, 2000, The Journal of pharmacology and experimental therapeutics.

Inhibition of in vivo myocardial ischemic and reperfusion injury by a synthetic manganese-based superoxide dismutase mimetic.

B. Lucchesi, D. Riley, C. Schasteen, 1994, The Journal of pharmacology and experimental therapeutics.

Inhibition of coronary artery reocclusion after thrombolysis with an RGD‐containing peptide with no significant effect on bleeding time

B. Lucchesi, M. Pierschbacher, E. Driscoll, 1993, Coronary artery disease.

Increased rat cardiac allograft survival by the glycosaminoglycan pentosan polysulfate.

S. Bolling, B. Lucchesi, J. Homeister, 1999, The Journal of surgical research.

Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.

B. Lucchesi, T. Barrett, Jinbao Huang, 2008, American journal of physiology. Heart and circulatory physiology.

Identification of hydrogen peroxide and hydroxyl radicals as mediators of leukocyte-induced myocardial dysfunction. Limitation of infarct size with neutrophil inhibition and depletion.

M. Hess, B. Lucchesi, G. Rowe, 1985, Advances in myocardiology.

The beneficial effects of oral ibuprofen on coronary artery thrombosis and myocardial ischemia in the conscious dog.

B. Lucchesi, L. Bush, J. Romson, 1980, The Journal of pharmacology and experimental therapeutics.

Electrolysis-induced myocardial dysfunction. A novel method for the study of free radical mediated tissue injury.

K. Stringer, B. Lucchesi, J. Mickelson, 1986, Journal of pharmacological methods.

Complement inhibitors in myocardial ischemia/reperfusion injury.

B. Lucchesi, K. Kilgore, 1997, Immunopharmacology.

Sulodexide: a renewed interest in this glycosaminoglycan.

B. Lucchesi, D. Lauver, Benedict R. Lucchesi, 2006, Cardiovascular drug reviews.

LU 51198, a highly sulfated, low-molecular-weight heparin derivative, prevents complement-mediated myocardial injury in the perfused rabbit heart.

B. Lucchesi, M. Gralinski, J. L. Park, 1997, The Journal of pharmacology and experimental therapeutics.

Clinical Pharmacokinetics of Intravenous and Oral Bretylium Tosylate in Survivors of Ventricular Tachycardia or Fibrillation: Clinical Application of a New Assay for Bretylium

J. Wagner, B. Pitt, B. Lucchesi, 1981, Journal of cardiovascular pharmacology.

Lanthanum staining of coronary microvascular endothelium: effects of ischemia reperfusion, propranolol, and atenolol.

B. Lucchesi, L. Bush, M. Shlafer, 1981, Microvascular research.

The cardiac beta-adrenergic receptor blocking actions of propranolol and its stereoisomers.

B. Lucchesi, L. S. Whitsitt, 1967, Life sciences.

PROPRANOLOL ON CORONARY VASCULAR RESISTANCE

B. Lucchesi, Leighton S. Whitsitt, 2005 .

Reperfusion injury after myocardial infarction: the role of free radicals and the inflammatory response.

B. Lucchesi, K. Kilgore, 1993, Clinical biochemistry.

THE EFFECTS OF PRONETHALOL AND ITS DEXTRO ISOMER UPON EXPERIMENTAL CARDIAC ARRHYTHMIAS.

B. Lucchesi, 1965, The Journal of pharmacology and experimental therapeutics.

Potential organ- or tumor-imaging agents XIX: radioiodinated antiarrhythmic drugs as potential myocardial imaging agents.

J. K. Gibson, B. Lucchesi, R. Counsell, 1980, Journal of pharmaceutical sciences.

Protective effects of dimethyl-propranolol (UM-272) during global ischemia of isolated feline hearts.

B. Lucchesi, L. Bush, J. Romson, 1980, The Journal of pharmacology and experimental therapeutics.

The effect of sympatholytic agents on the cardiovascular responses produced by the injection of acetylstrophanthidin into the cerebral ventricles.

B. Lucchesi, J. L. Stickney, 1969, European journal of pharmacology.

Cardiac electrophysiologic interactions of bepridil, a new calcium antagonist, with enflurane, halothane, and isoflurane.

B. Lucchesi, C. Hantler, J. Lynch, 1988, Journal of cardiothoracic anesthesia.

THE ACTION OF NETHALIDE UPON EXPERIMENTALLY INDUCED CARDIAC ARRHYTHMIAS.

B. Lucchesi, 1964, The Journal of pharmacology and experimental therapeutics.

Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations.

B. Pitt, J. Anderson, B. Lucchesi, 1980, The American journal of cardiology.

Changes in myocardial threshold. Physiologic and pharmacologic factors in patients with implanted pacemakers.

B. Lucchesi, R. Fletcher, T. Preston, 1967, American heart journal.

Failure of potassium canrenoate to alter experimentally induced digitalis arrhythmias.

B. Lucchesi, N. Haley, 1973, European journal of pharmacology.

The influence of dichloroiso-proterenol (DCI) and related compounds upon ouabain and acetylstrophanthidin induced cardiac arrhythmias.

B. Lucchesi, H. Hardman, H. F. Hardman, 1961, The Journal of pharmacology and experimental therapeutics.

Thrombostatin Inhibits Cyclic Flow Variations in Stenosed Canine Coronary Arteries

A. Schmaier, D. Normolle, S. Werns, 2001, Thrombosis and Haemostasis.

Thrombostatin Inhibits Induced Canine Coronary Thrombosis

D. Normolle, S. Werns, B. Lucchesi, 1999, Thrombosis and Haemostasis.

Reduction of Myocardial Necrosis after Glycosaminoglycan Administration: Effects of a Single Intravenous Administration of Heparin or N-Acetylheparin 2 Hours before Regional Ischemia and Reperfusion

B. Lucchesi, G. Friedrichs, M. Gralinski, 1996 .

Effects of Beta‐Receptor Blockade and Glucagon on the Atrioventricular Transmission System in the Dog

B. Lucchesi, Leighton S. Whitsitt, 1968, Circulation research.

The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.

B. Lucchesi, R. Counsell, F. Kniffen, 1973, The Journal of pharmacology and experimental therapeutics.

Sensitive gas chromatographic assay for the quantitation of bretylium in plasma, urine and myocardial tissue.

P. Stetson, B. Lucchesi, E. Patterson, 1980, Journal of chromatography.

Myocardial ischemia, reperfusion and free radical injury.

B. Lucchesi, Benedict R. Lucchesi, 1990, The American journal of cardiology.

Cardiac Actions of Glucagon

B. Lucchesi, 1968, Circulation research.

Myocardial Infarct Quantification in the Dog by Single Photon Emission Computed Tomography

W. Rogers, S. Brody, B. Lucchesi, 1978, Circulation.

Myocardial threshold in patients with artificial pacemakers.

D. L. Bowers, B. Lucchesi, T. Preston, 1966, The American journal of cardiology.

EFFECT OF QUINIDINE AND PROCAINE AMIDE UPON ACETYLSTROPHANTHIDIN CARDIOTOXICITY.

B. Lucchesi, R. Shivak, 1964, Journal of Pharmacology and Experimental Therapeutics.

The action of dichloroisoproterenol (DCI) and several other pharmacological agents upon the aconitine-induced ventricular arrhythmia in the isolated rabbit heart.

B. Lucchesi, 1962, Journal of Pharmacology and Experimental Therapeutics.

The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system.

B. Lucchesi, K. L. Murphy, K. Kilgore, 1999, Transplantation proceedings.

Care , and the animal care use program conforms to the standards in the Guide for the Care and Use of Laboratory Animals

B. Lucchesi, N. Obeid, E. Booth, 2005 .

Care , and the animal care use program conforms to the standards in the Guide for the Care and Use of Laboratory Animals

B. Lucchesi, N. Obeid, E. Booth, 2005 .

The Role of Complement in Myocardial Inflammation and Reperfusion Injury

B. Lucchesi, E. J. Tanhehco, 2003 .

Reviparin-sodium prevents complement-mediated myocardial injury in the isolated rabbit heart.

B. Lucchesi, K. Kilgore, M. Gralinski, 1997, Journal of cardiovascular pharmacology.

Purification and characterization of platelet aggregation inhibitors from snake venoms.

M. Trikha, B. Lucchesi, F. Markland, 1994, Thrombosis Research.

Oral Pretreatment With Liposomal Glutathione Attenuates Reperfusion Injury in Rabbit Isolated Hearts

B. Lucchesi, D. Lauver, Nayiri M. Kaissarian, 2013, Journal of cardiovascular pharmacology.

Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol.

J. Kipnis, B. Lucchesi, S. Jolly, 1987, Pharmacology.

Complement, neutrophils and free radicals: mediators of reperfusion injury.

B. Lucchesi, 1994, Arzneimittel-Forschung.

C-Reactive-Protein-Associated Increase in Myocardial Infarct Size After Ischemia/Reperfusion

B. Lucchesi, T. Barrett, R. Marks, 2002, Journal of Pharmacology and Experimental Therapeutics.

Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion.

B. Lucchesi, K. Kilgore, E. J. Tanhehco, 1999, The Journal of pharmacology and experimental therapeutics.

Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1

William L. Smith, B. Lucchesi, R. Trievel, 2009, Proceedings of the National Academy of Sciences.

Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model.

B. Lucchesi, S. Rebello, T. Sakurama, 1999, European journal of pharmacology.

Effect of diltiazem on experimental coronary artery thrombosis in dogs.

B. Lucchesi, W. Schumacher, 1990, Pharmacology.

Cardioprotective effects of amlodipine on ischemia and reperfusion in two experimental models.

B. Lucchesi, P. Hoff, Y. Tamura, 1990, The American journal of cardiology.

MYOCARDIAL REPERFUSION INJURY

B. Lucchesi, 1990 .

Cardioprotective effects of amlodipine in the ischemic-reperfused heart.

B. Lucchesi, Y. Tamura, 1989, American heart journal.

Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.

K. Gallagher, M. Schork, L. Chi, 1989, Circulation research.

The Reduction of Ultimate Infarct Size: State of the Art and Goals for the Future

B. Lucchesi, 1987 .

[Limitation of myocardial infarct size by polyethylene glycol-conjugated superoxide dismutase in a canine model of 90 min coronary occlusion followed by 4 days of reperfusion].

B. Lucchesi, S. Saito, Y. Tamura, 1989, Kokyu to junkan. Respiration & circulation.

Myocardial protection with preconditioning.

Juan A. Vasquez, K. Gallagher, B. Lucchesi, 1990, Circulation.

Effect of Sodium/Hydrogen Exchange Inhibition on Myocardial Infarct Size after Coronary Artery Thrombosis and Thrombolysis

B. Lucchesi, T. Barrett, J. Hennan, 2006, Pharmacology.

Effect of Ramiprilat or Captopril on Myocardial Infarct Size: Assessment in Canine Models of Ischemia Alone and Ischemia with Reperfusion

B. Lucchesi, E. Driscoll, S. Black, 1998, Pharmacology.

Reduction of Myocardial Infarct Size in the Rabbit by a Carbohydrate Analog of Sialyl Lewisx

James L. Park, L. Chi, B. Lucchesi, 1996, Journal of cardiovascular pharmacology and therapeutics.

Thrombostatin FM compounds: direct thrombin inhibitors – mechanism of action in vitro and in vivo

A. Schmaier, E. Di Cera, B. Lucchesi, 2008, Journal of thrombosis and haemostasis : JTH.

Protection of Myocardial Function and Coronary Vasculature by Streptokinase

P. J. Simpson, B. Lucchesi, J. Mickelson, 1988, Journal of cardiovascular pharmacology.

Superoxide dismutase does not cause scar thinning after myocardial infarction.

A. Buda, B. Pitt, S. Phan, 1987, Journal of the American College of Cardiology.

cAln Official Jiournal ofthecAmericanHeart cyAssociation, Inc. FEATURES Freeradicals andmyocardial injury: pharmacologic

S. Werns, B. Lucchesi, M. Shea, 1986 .

Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death.

B. Lucchesi, E Patterson, E. Patterson, 1982, The American journal of cardiology.

The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.

L. Chi, B. Lucchesi, D. Mu, 1991, The Journal of pharmacology and experimental therapeutics.

Lethal Myocardial “Reperfusion Injury”

B. Lucchesi, 2004, Journal of Thrombosis and Thrombolysis.

17β-Estradiol as a Receptor-Mediated Cardioprotective Agent

B. Lucchesi, M. Marchesi, E. Booth, 2003, Journal of Pharmacology and Experimental Therapeutics.

Antiarrhythmic Actions of Left Stellectomy in Digitalis‐Mediated Malignant Ventricular Arrhythmias in the Postinfarcted Canine Heart

B. Lucchesi, D. Sanders, S. Nelson, 1988, Journal of cardiovascular pharmacology.

Antifibrillatory action of bretylium: role of the sympathetic nervous system.

B. Lucchesi, G. Kopia, 1987, Pharmacology.

Apolipoprotein A-IMilano and 1-Palmitoyl-2-oleoyl Phosphatidylcholine Complex (ETC-216) Protects the in Vivo Rabbit Heart from Regional Ischemia-Reperfusion Injury

B. Lucchesi, C. Bisgaier, M. Marchesi, 2004, Journal of Pharmacology and Experimental Therapeutics.

Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart.

B. Lucchesi, P. Satoh, J. Homeister, 1993, Journal of immunology.

Ibuprofen-mediated infarct size reduction: effects on regional myocardial function in canine myocardial infarction in canine myocardial infarction.

B. Pitt, M. Schork, B. Lucchesi, 1982, The American journal of cardiology.

The role of nicotine as a determinant of cigarette smoking frequency in man with observations of certain cardiovascular effects associated with the tobacco alkaloid

B. Lucchesi, C. Schuster, G. Emley, 1967, Clinical pharmacology and therapeutics.

Free radicals upregulate complement expression in rabbit isolated heart.

P. Mcgeer, B. Lucchesi, K. Yasojima, 2000, American journal of physiology. Heart and circulatory physiology.

Dermatan disulfate (Intimatan) prevents complement-mediated myocardial injury in the human-plasma-perfused rabbit heart.

Andrew J. White, B. Lucchesi, T. Hong, 2005, International immunopharmacology.

The semisynthetic polysaccharide pentosan polysulfate prevents complement-mediated myocardial injury in the rabbit perfused heart.

B. Lucchesi, K. Kilgore, E. J. Tanhehco, 1998, The Journal of pharmacology and experimental therapeutics.

The positive inotropic action of insulin in the canine heart.

B. Lucchesi, M. Medina, F. Kniffen, 1972, European journal of pharmacology.

Serial Electrophysiologic Effects of Bretylium in Man and Their Correlation with Plasma Concentrations

B. Lucchesi, E. Patterson, H. Marshall, 1982, Journal of cardiovascular pharmacology.

Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.

J. K. Gibson, B. Lucchesi, E. Patterson, 1981, The Journal of pharmacology and experimental therapeutics.

Clinical pharmacology of antiarrhythmic therapy

B. Lucchesi, R. Schwarz, J. V. Dingell, 1984 .

Recombinant Kunitz Protease Inhibitory Domain of the Amyloid β-Protein Precursor as an Anticoagulant in Venovenous Extracorporeal Circulation in Rabbits

A. Schmaier, B. Lucchesi, S. Rebello, 1999, Thrombosis and Haemostasis.

Bretylium: a prototype for future development of antidysrhythmic agents.

B. Lucchesi, E. Patterson, Benedict R. Lucchesi, 1983, American heart journal.

Recombinant hirudin reduces the incidence of thrombotic occlusion in a canine model of coronary vascular injury

B. Lucchesi, P. Hoff, J. Homeister, 1991 .

Do catecholamines play a physiologic role in regulating corpus luteum function in the pseudopregnant rabbit?

B. Lucchesi, J. Gadsby, P. Keyes, 1985, Biology of reproduction.

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

T. Wakefield, B. Lucchesi, J. Diaz, 2011, Journal of visualized experiments : JoVE.

Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.

B. Lucchesi, R. Hodgeman, 1971, The Journal of pharmacology and experimental therapeutics.

Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog.

B. Pitt, B. Lucchesi, J. Romson, 1984, European journal of pharmacology.

Estrogen Protects the Heart From Ischemia-Reperfusion Injury via COX-2-Derived PGI2

B. Lucchesi, E. Booth, A. Knittel, 2008, Journal of cardiovascular pharmacology.

Inhibition of Platelet-Activating Factor Fails to Limit Ischemia and Reperfusion-Induced Myocardial Damage

B. Lucchesi, E. Driscoll, S. Black, 1992, Journal of cardiovascular pharmacology.

The effect of diltiazem on coronary thrombosis in the conscious canine.

B. Lucchesi, L. Bush, J. Romson, 1982, European journal of pharmacology.

Attenuates Myocardial Ischemia / Reperfusion Injury and the Deposition of C-Reactive Protein in Areas of Infarction without Affecting Hemostasis

A. J. White, B. Lucchesi, E. Poradosu, 2004 .

Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium.

J. K. Gibson, B. Lucchesi, 1980, The Journal of pharmacology and experimental therapeutics.

Electrophysiological effects of prazosin during acute myocardial ischemia

B. Lucchesi, D. Wilber, J. Lynch, 1986 .

Electrophysiologic effects of prazosin during acute myocardial ischemia.

B. Lucchesi, D. Wilber, J. Lynch, 1986, European journal of pharmacology.

Inflammation and myocardial infarction.

S. Werns, B. Lucchesi, 1987, British medical bulletin.

Electrophysiologic actions of pirmenol in dogs with recent myocardial infarction.

L. DiCarlo, B. Lucchesi, J. Lynch, 1986, American heart journal.

Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIb/IIIa Receptor Antagonists

J. Faul, B. Lucchesi, S. Rebello, 2004, Journal of Thrombosis and Thrombolysis.

Effect of Ado A1- and A2-receptor activation on ventricular fibrillation during hypoxia-reoxygenation.

J. Oh, L. Chi, B. Lucchesi, 1994, The American journal of physiology.

Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction.

L. DiCarlo, B. Lucchesi, J. Lynch, 1987, Pharmacology.

Antithrombotic effects of BMY21190, an inhibitor of cAMP phosphodiesterase, in a canine model of coronary artery thrombosis.

M. Minami, B. Lucchesi, E. Driscoll, 1993, Japanese circulation journal.

Effect of hypoxia and reoxygenation on the isolated rabbit heart determined by monoclonal antimyosin antibody uptake.

B. Lucchesi, K. Kilgore, 1993, Cardiovascular research.

Comparative effects of aspartate and glutamate during myocardial ischemia.

S. Warren, B. Lucchesi, L. Bush, 1981, Pharmacology.

The effects of BL-4162A on the development of coronary artery thrombosis in the conscious dog

B. Lucchesi, C. Drescher, A. Grocock, 1979 .

Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure.

B. Lucchesi, M. Kirsch, N. Nobel-Allen, 1973, The Journal of pharmacology and experimental therapeutics.

The effect of dietary supplementation of fish oil on experimental myocardial infarction.

B. Lucchesi, B. Culp, B. Pitt, 1980, Prostaglandins.

Potassium channel openers are likely to be proarrhythmic in the diseased human heart.

B. Lucchesi, S. Black, 1994, Cardiovascular research.

Prevention of Chronic Canine Ventricular Tachyarrhythmias with Bretylium Tosylate

J. K. Gibson, B. Lucchesi, E. Patterson, 1981, Circulation.

Prevention ofChronic Canine Ventricular Tachyarrhythmias withBretylium Tosylate

B. Lucchesi, 1981 .

Neutrophils and altered myocardial function.

B. Lucchesi, K. Kilgore, 2000, American heart journal.

The role of adhesion molecules in cardiovascular pharmacology: meeting review.

P. J. Simpson, B. Lucchesi, R. Shebuski, 1995, The Journal of pharmacology and experimental therapeutics.

Changes in cardiac muscle function and biochemistry produced by long-term amiodarone and amiodarone + triiodothyronine administration in the rabbit.

M. Khazaeli, B. Lucchesi, D. Montgomery, 1987, Pharmacology.

Effects of Combined Thromboxane Synthetase Inhibition/Thromboxane Receptor Antagonism in Two Models of Sudden Cardiac Death in the Canine: Limited Role for Thromboxane

L. Chi, A. Uprichard, B. Lucchesi, 1990, Journal of cardiovascular pharmacology.

Potentiation of the antithrombotic effect of prostacyclin by simultaneous administration of aminophylline in a canine model of coronary artery thrombosis.

B. Lucchesi, B. Hook, J. Romson, 1983, The Journal of pharmacology and experimental therapeutics.

Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction.

J. K. Gibson, B. Lucchesi, E. Patterson, 1988, Pharmacology.

Methylprednisolone Sodium Succinate Treatment in Global Ischemia of the Cat Isolated Heart

B. Lucchesi, W. Vogel, Daniel Lum, 1979, Journal of cardiovascular pharmacology.

Long-term intravenous infusion of antiarrhythmic drugs using a totally implanted drug delivery system.

B. Pitt, J. Anderson, B. Lucchesi, 1981, The American journal of cardiology.

Antifibrillatory and Profibrillatory Actions of Selected Class I Antiarrhythmic Agents

L. Chi, B. Lucchesi, S. O. Fagbemi, 1993, Journal of cardiovascular pharmacology.

Hypothyroidism Renders Protection Against Lethal Ventricular Arrhythmias in a Conscious Canine Model of Sudden Death

A. Uprichard, B. Lucchesi, Bramahn . Singh, 1991, Journal of cardiovascular pharmacology.

Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine.

B. Lucchesi, S. Nelson, J. Lynch, 1987, The Journal of pharmacology and experimental therapeutics.

Development of Ventricular Tachyarrhythmias in the Conscious Canine During the Recovery Phase of Experimental Ischemic Injury: Effect of Bethanidine Administration

B. Lucchesi, E. Patterson, David J. Amalfitano, 1984, Journal of cardiovascular pharmacology.

Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.

L. Chi, A. Uprichard, B. Lucchesi, 1989, The Journal of pharmacology and experimental therapeutics.

α-Adrenergic Influences in Canine Ischemic Sudden Death

B. Lucchesi, D. Wilber, J. Lynch, 1987 .

Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death.

A. Uprichard, B. Lucchesi, J. Lynch, 1988, Pharmacology.

Preclinical assessment of antiarrhythmic drugs.

B. Lucchesi, J. Lynch, 1986, Federation proceedings.

MS‐551 Protects Against Ventricular Fibrillation in a Chronic Canine Model of Sudden Cardiac Death

L. Chi, B. Lucchesi, G. Friedrichs, 1995, Journal of cardiovascular pharmacology.

The autonomic nervous system, myocardial infarct size and ventricular fibrillation.

B. Lucchesi, G. Friedrichs, S. Black, 1993, Journal of molecular and cellular cardiology.

Antiarrhythmic Agent, MS‐551, Protects Against Pinacidil + Hypoxia‐Induced Ventricular Fibrillation in Langendorff‐Perfused Rabbit Isolated Heart

L. Chi, B. Lucchesi, G. Friedrichs, 1994, Journal of cardiovascular pharmacology.

Experimental Coronary Artery Thrombosis in the Absence of Thromboxane A2 Synthesis: Evidence for Alternate Pathways for Coronary Thrombosis

B. Lucchesi, S. Jolly, B. Hook, 1985, Journal of cardiovascular pharmacology.

The antiarrhythmic properties of ICI 46037, a quaternary analog of propranolol.

B. Lucchesi, T. Iwami, 1968, The Journal of pharmacology and experimental therapeutics.

The cardiac pharmacology of tolbutamide.

B. Lucchesi, G. Curtis, J. Setchfield, 1975, The Journal of pharmacology and experimental therapeutics.

Therapeutic advances in the management of cardiac arrhythmias: Part I. Disopyramide

B. Lucchesi, E. Patterson, 1982 .

Protection of Reperfused Ischemic Canine Myocardium by CI‐922, a New Inhibitor of Leukocyte Activation

P. J. Simpson, S. Werns, B. Lucchesi, 1988, Journal of cardiovascular pharmacology.

17Beta-estradiol as a receptor-mediated cardioprotective agent.

B. Lucchesi, M. Marchesi, E. Kilbourne, 2003, The Journal of pharmacology and experimental therapeutics.

Improved coronary blood flow after streptokinase thrombolysis with thromboxane synthetase inhibition in an experimental canine model

P. J. Simpson, B. Lucchesi, C. Smith, 1986 .